Latest article
Novo Nordisk presents trial outcomes of Xultophy for kind 2 diabetes
Novo Nordisk said Monday that its type 2 diabetes treatment Xultophy showed superior efficacy in reducing hemoglobin A1c (HbA1c) levels, weight change and lower...
